Evaluation of metabolic, reproductive, and gut microbiota alterations in a comparative study of different preclinical models of polycystic ovary syndrome
Journal of Neuroendocrinology · 2026
DOI: 10.1111/jne.70247 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Neuroendocrinology, 2026. Verfasst von Nisha H Khobragade und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gujarat Technological University, Ahmedabad, India. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Gastrointestinal Microbiome, Reproduction. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a multifaceted, complex metabolic and endocrine disease where gut flora is considered an important factor in causing PCOS. This study aimed to identify a suitable PCOS model that contributes to gut microbial dysbiosis and metabolic and hormonal disturbances. Prepubertal SD rats were administered with normal control (NC), dihydrotestosterone (DHT), DHT with fructose (F), DHT+ high fat diet (HFD) for 91 days, dehydroepiandrosterone (DHEA), DHEA with fructose, DHEA with HFD for 30 days, sodium valproate (SV), sodium valproate with fructose, and sodium valproate with HFD for 21 days. The estrous cycles were assessed over this timeframe. At the end of the experiment, superoxide dismutase and uterine and ovarian morphology were evaluated, along with hormone levels, lipid profiles, and 16S rRNA genomic sequencing. All models exhibited PCOS characteristics, including hormonal imbalances, insulin resistance ( p ≤ .001), multiple follicular cysts on ultrasonography, and histological alterations. Gut microbial dysbiosis was observed across all PCOS‐induced groups; however, the DHT alone group showed more pronounced alterations in microbial composition than the other experimental groups. Specifically, the DHT alone group exhibited reduced abundance of Firmicutes and increased abundance of Proteobacteria. Among the evaluated models, the DHT‐only model showed more pronounced metabolic, hormonal, reproductive, and gut microbial alterations and may serve as a suitable model for PCOS research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gujarat Technological University, Ahmedabad, India.
- Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, India.
- Department of Pharmaceutical Chemistry, L. M. College of Pharmacy, Ahmedabad, India.
ORCID-Profile: Nisha H Khobragade, Devang B Sheth, Chirag A Patel, Jayesh V Beladiya
Zitieren
APA
Khobragade, N. H., Sheth, D. B., Patel, C. A., Beladiya, J. V., Patel, S., Dalal, M., & Dholakia, S. (2026). Evaluation of metabolic, reproductive, and gut microbiota alterations in a comparative study of different preclinical models of polycystic ovary syndrome. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.70247
Vancouver
Khobragade NH, Sheth DB, Patel CA, Beladiya JV, Patel S, Dalal M, et al. Evaluation of metabolic, reproductive, and gut microbiota alterations in a comparative study of different preclinical models of polycystic ovary syndrome. Journal of Neuroendocrinology. 2026. doi:10.1111/jne.70247
BibTeX
@article{Khobragade2026,
author = {Khobragade, Nisha H and Sheth, Devang B and Patel, Chirag A and Beladiya, Jayesh V and Patel, Sandip and Dalal, Mittal and Dholakia, Sandip},
title = {Evaluation of metabolic, reproductive, and gut microbiota alterations in a comparative study of different preclinical models of polycystic ovary syndrome},
journal = {Journal of Neuroendocrinology},
year = {2026},
doi = {10.1111/jne.70247}
}
EUVIMED